Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Open Forum Infectious Diseases, 12 (Supplement 1)
Compounded semaglutide ($189/mo) and tirzepatide ($289/mo) offer cost-effective alternatives to branded medications while maintaining pharmaceutical oversight and safety verification
They not only delay the time until lower-cost generic or biosimilar products can enter the market but also stifle the innovation pipeline, tying up money in expensive litigation rather than investing in research
Meier J, Weyhe D, Michaely M, Senkal M, Zumtobel V, Nauck M, Holst J, Schmidt W, Gallwitz B (2004)
US$ 24.77
US$ 27.96
US$ 20.71
US$ 24.84
US$ 21.75
US$ 20.21
US$ 28.11
US$ 29.35
US$ 24.39
US$ 24.83
US$ 25.56
